Terms: = Head and neck cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb
208 results:
1. Evaluation of Some Prognostic Biomarkers in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma.
Alabiad MA; Said WMM; Adim AMA; Alorini M; Shalaby AM; Samy W; Elshorbagy S; Mandour D; Saber IM; Yahia AIO; Khairy DA
Iran J Med Sci; 2024 Mar; 49(3):156-166. PubMed ID: 38584650
[TBL] [Abstract] [Full Text] [Related]
2. Proceedings of the 2024 North American Society of head and neck Pathology Companion Meeting, Baltimore, MD, March 24, 2024: Navigating Ancillary Studies in Basaloid/Blue Salivary Tumors.
Wong KS
Head Neck Pathol; 2024 Mar; 18(1):24. PubMed ID: 38526755
[TBL] [Abstract] [Full Text] [Related]
3. myb/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma.
Cheng L; Deng X; Le Y
Endokrynol Pol; 2024; 75(1):27-34. PubMed ID: 38497387
[TBL] [Abstract] [Full Text] [Related]
4. myb alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
Huang J; Fehr A; Jäwert F; Nilsson JA; Morris LGT; Stenman G; Andersson MK
Oral Oncol; 2024 Apr; 151():106763. PubMed ID: 38493544
[TBL] [Abstract] [Full Text] [Related]
5. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract] [Full Text] [Related]
6. [Correlation of myb/NFIB gene fusion with the grade and prognosis of head and neck adenoid cystic carcinoma and the concordance of two detection methods].
Zhu YL; Li Y; Mu JL; Liu WC; Li X; Lu HZ
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):149-154. PubMed ID: 38281782
[No Abstract] [Full Text] [Related]
7. Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication.
Fujii S; Hasegawa K; Maehara T; Kurppa KJ; Heikinheimo K; Warner KA; Maruyama S; Tajiri Y; Nör JE; Tanuma JI; Kawano S; Kiyoshima T
Pathol Res Pract; 2024 Feb; 254():155148. PubMed ID: 38277753
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
9. The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of head and neck.
Naito T; Noji R; Kugimoto T; Kuroshima T; Tomioka H; Fujiwara S; Suenaga M; Harada H; Kano Y
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138214
[No Abstract] [Full Text] [Related]
10. PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
Ferrarotto R; Swiecicki PL; Zandberg DP; Baiocchi RA; Wesolowski R; Rodriguez CP; McKean M; Kang H; Monga V; Nath R; Palmisiano N; Babbar N; Sun W; Hanna GJ
Oral Oncol; 2024 Feb; 149():106634. PubMed ID: 38118249
[TBL] [Abstract] [Full Text] [Related]
11. The mitotic checkpoint kinase BUB1 is a direct and actionable target of myb in adenoid cystic carcinoma.
Cicirò Y; Ragusa D; Nevado PT; Lattanzio R; Sala G; DesRochers T; Millard M; Andersson MK; Stenman G; Sala A
FEBS Lett; 2024 Jan; 598(2):252-265. PubMed ID: 38112379
[TBL] [Abstract] [Full Text] [Related]
12. Current diagnosis and treatment of salivary gland-type tumors of the lung.
Horio Y; Kuroda H; Masago K; Matsushita H; Sasaki E; Fujiwara Y
Jpn J Clin Oncol; 2024 Mar; 54(3):229-247. PubMed ID: 38018262
[TBL] [Abstract] [Full Text] [Related]
13. Diagnosis of Adenoid Cystic Carcinoma with Striking Tubular Hypereosinophilia by myb and EWSR1 Breakapart Fluorescence In Situ Hybridization.
Yadav U; Mahendru R; Sharma J; Kakkar A
Head Neck Pathol; 2023 Dec; 17(4):940-951. PubMed ID: 38010473
[TBL] [Abstract] [Full Text] [Related]
14. A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Ho AL; Foster NR; Deraje Vasudeva S; Katabi N; Antonescu CR; Frenette GP; Pfister DG; Erlichman C; Schwartz GK
Cancer; 2024 Mar; 130(5):702-712. PubMed ID: 37947157
[TBL] [Abstract] [Full Text] [Related]
15. Cell-type-specific tumour sensitivity identified with a bromodomain targeting PROTAC in adenoid cystic carcinoma.
Rose AJ; Fleming MM; Francis JC; Ning J; Patrikeev A; Chauhan R; Harrington KJ; Swain A
J Pathol; 2024 Jan; 262(1):37-49. PubMed ID: 37792636
[TBL] [Abstract] [Full Text] [Related]
16. A Review of the Molecular Landscape of Adenoid Cystic Carcinoma of the Lacrimal Gland.
Powell SK; Kulakova K; Kennedy S
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762061
[TBL] [Abstract] [Full Text] [Related]
17. Molecular characterisation of tumours of the lacrimal apparatus.
Vibert R; Cyrta J; Girard E; Vacher S; Dupain C; Antonio S; Wong J; Baulande S; De Sousa JMF; Vincent-Salomon A; Masliah-Planchon J; Girard N; Le Tourneau C; Kamal M; Bièche I
Histopathology; 2023 Dec; 83(6):925-935. PubMed ID: 37706251
[TBL] [Abstract] [Full Text] [Related]
18. Identification and functional analysis of novel biomarkers in adenoid cystic carcinoma.
Su J; Zhou W; Yuan H; Wang H; Zhang H
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):203-207. PubMed ID: 37605568
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers.
Persson M; Andersson MK; Sahlin PE; Mitani Y; Brandwein-Weber MS; Frierson HF; Moskaluk C; Fonseca I; Ferrarotto R; Boecker W; Loening T; El-Naggar AK; Stenman G
J Pathol; 2023 Nov; 261(3):256-268. PubMed ID: 37565350
[TBL] [Abstract] [Full Text] [Related]
20. Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review.
Chen Z; Jiang J; Fan Y; Lu H
Diagn Pathol; 2023 May; 18(1):65. PubMed ID: 37198615
[TBL] [Abstract] [Full Text] [Related]
[Next]
